Pharmaceutical Biocatalysis:Important Enzymes, Novel Targets, and Therapies(Jenny Stanford Series on Biocatalysis)

药物生物催化:重要的酶、新型靶标与疗法

生物工程

原   价:
2642.5
售   价:
2114.00
优惠
平台大促 低至8折优惠
发货周期:预计5-7周发货
作      者
出  版 社
出版时间
2020年11月02日
装      帧
精装
ISBN
9789814877138
复制
页      码
460
开      本
6 x 9
语      种
英文
综合评分
暂无评分
我 要 买
- +
库存 50 本
  • 图书详情
  • 目次
  • 买家须知
  • 书评(0)
  • 权威书评(0)
图书简介
This volume of Pharmaceutical Biocatalysis starts with a discussion on the importance of biocatalytic synthesis approaches for a sustainable and environmentally friendly production of pharmaceuticals and active pharmaceutical ingredients. Among the enzymes discussed in detail with respect to their pharmaceutical relevance are cyclic nucleotide phosphodiesterases playing an important role in modulating signal transduction in various cell types; human DOPA decarboxylase, related to Parkinson’s disease and aromatic amino acid decarboxylase deficiency; and phospholipase D enzymes as drug targets. Isocitrate dehydrogenase 1 and 2 mutations are novel therapeutic targets in acute myeloid leukemia. An additional chapter is devoted to the use of enzymes for prodrug activation in cancer therapy. The other topics include small-molecule inhibitors targeting receptor tyrosine kinases in cancer, ß-Lactams and related compounds as antibacterials, non-vitamin K oral anticoagulants for the treatment of thromboembolic diseases, and the molecular mechanisms for statin pleiotropy and its clinical relevance in cardiovascular diseases. The last chapter is a review of lysosomal storage disorders with an overview of approved drugs for treating these disorders by enzyme replacement therapy.
本书暂无推荐
本书暂无推荐
看了又看
  • 上一个
  • 下一个